Personalized healthcare has the power to improve patient outcomes by individualizing the patient journey. It’s a concept that can be applied in both diagnosis and treatment. Technological progress has led to the development of diagnostic solutions to enable advances in the detection of diseases as well as more efficient monitoring during treatment.

More people than ever are adopting digital tools to take control of their personal health. But, enhancing the overall health of a population depends on proving the value of innovative diagnostic solutions to payers and bringing them into health systems at scale. How can diagnostics support better clinical decision-making and ultimately deliver a more personalized patient experience? What are some of the transformative diagnostic solutions at the forefront of personalized healthcare? Where is investment in health systems most needed to facilitate the growth of personalized healthcare supported by innovation in diagnostics?

Hosted by the Financial Times in partnership with Roche, this virtual event will discuss the role of diagnostics as a critical element in healthcare decision-making, as well as its potential in supporting the rise of personalized healthcare.

Understand

The big picture, not just the individual strands of the business you work in

Connect

And build relationships with some of the biggest names in your industry

Discover

New approaches and strategies to help win market share

Premier Digital Events Supported by the World's Best Journalism

Using leading digital technology, we have now taken our content, global audience reach and engagement to a new level through a series of unmissable virtual events. Our compelling events are chaired by respected FT journalists, feature the most senior and thought-provoking decision-makers in business, finance and politics, all accessible from your office or home.

© Financial Times Live

FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice